Goldman Sachs: Madrigal Pharma Has Blockbuster Potential In Liver, Cholesterol Treatments
March 23, 2018 at 12:54 PM EDT
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), a clinical-stage biotechnology company, could spring a surprise in thenon-alcoholic ...